penicillin g has been researched along with Neonatal Sepsis in 5 studies
Penicillin G: A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission.
benzylpenicillin : A penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group.
Neonatal Sepsis: Blood infection that occurs in an infant younger than 90 days old. Early-onset sepsis is seen in the first week of life and most often appears within 24 hours of birth. Late-onset occurs after 1 week and before 3 months of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Therefore, we compared parenteral benzylpenicillin plus gentamicin with ceftriaxone as first-line treatment, assessing outcome and adverse events." | 2.84 | The Treatment of Possible Severe Infection in Infants: An Open Randomized Safety Trial of Parenteral Benzylpenicillin and Gentamicin Versus Ceftriaxone in Infants <60 days of Age in Malawi. ( Banda, FM; Chiume, M; Dube, Q; Heyderman, RS; Mallewa, M; Molyneux, EM; Schwalbe, EC; Singini, I, 2017) |
| "Adequate dosage recommendations are imperative for successful treatment of invasive infections." | 1.62 | Benzylpenicillin Serum Concentrations in Neonates With Group B Streptococci Sepsis or Meningitis: A Descriptive Cohort Study. ( Bekker, V; Bredius, RGM; Jansen, SJ; Lopriore, E; Moes, DJAR; van der Beek, MT, 2021) |
| "Ampicillin resistance was found in 113 cases (95%), cefotaxime 104 (87%), gentamicin 101 (85%), AmpGen 101 (85%), piperacillin-tazobactam 47 (39%), amikacin 10 (8." | 1.62 | Prevalence and risk factors for antimicrobial resistance among newborns with gram-negative sepsis. ( Abayneh, M; Akeju, O; Ambachew, R; Bekele, D; Carvalho, MJ; Chan, GJ; Gebreyohannes, Z; Goddard, FGB; Metaferia, G; Milton, R; Odumade, OA; Sands, K; Solomon, S; Thomson, K; Van Wickle, K; Walsh, TR, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Narayanan, N | 1 |
| Williams, RL | 1 |
| Turner, PC | 1 |
| Paul, SP | 1 |
| Jansen, SJ | 1 |
| Lopriore, E | 1 |
| Bredius, RGM | 1 |
| van der Beek, MT | 1 |
| Moes, DJAR | 1 |
| Bekker, V | 1 |
| Solomon, S | 1 |
| Akeju, O | 1 |
| Odumade, OA | 1 |
| Ambachew, R | 1 |
| Gebreyohannes, Z | 1 |
| Van Wickle, K | 1 |
| Abayneh, M | 1 |
| Metaferia, G | 1 |
| Carvalho, MJ | 1 |
| Thomson, K | 1 |
| Sands, K | 1 |
| Walsh, TR | 1 |
| Milton, R | 1 |
| Goddard, FGB | 1 |
| Bekele, D | 1 |
| Chan, GJ | 1 |
| Salava, A | 1 |
| Aho, V | 1 |
| Lybeck, E | 1 |
| Pereira, P | 1 |
| Paulin, L | 1 |
| Nupponen, I | 1 |
| Ranki, A | 1 |
| Auvinen, P | 1 |
| Andersson, S | 1 |
| Lauerma, A | 1 |
| Molyneux, EM | 1 |
| Dube, Q | 1 |
| Banda, FM | 1 |
| Chiume, M | 1 |
| Singini, I | 1 |
| Mallewa, M | 1 |
| Schwalbe, EC | 1 |
| Heyderman, RS | 1 |
1 trial available for penicillin g and Neonatal Sepsis
| Article | Year |
|---|---|
The Treatment of Possible Severe Infection in Infants: An Open Randomized Safety Trial of Parenteral Benzylpenicillin and Gentamicin Versus Ceftriaxone in Infants <60 days of Age in Malawi.
Topics: Anti-Bacterial Agents; Bilirubin; Ceftriaxone; Gentamicins; Hearing Loss; Humans; Infant; Infant, Ne | 2017 |
4 other studies available for penicillin g and Neonatal Sepsis
| Article | Year |
|---|---|
Early-onset neonatal sepsis caused by
Topics: Anti-Bacterial Agents; Female; Gentamicins; Humans; Infant, Newborn; Neonatal Sepsis; Penicillin G; | 2020 |
Benzylpenicillin Serum Concentrations in Neonates With Group B Streptococci Sepsis or Meningitis: A Descriptive Cohort Study.
Topics: Anti-Bacterial Agents; Cohort Studies; Drug Monitoring; Female; Humans; Infant, Newborn; Male; Menin | 2021 |
Prevalence and risk factors for antimicrobial resistance among newborns with gram-negative sepsis.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ethiopia; F | 2021 |
Loss of cutaneous microbial diversity during first 3 weeks of life in very low birthweight infants.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Humans; Incubators, Infant; Infant, Newborn; Infant, | 2017 |